Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985 …
RA Seger, T Gungor, BH Belohradsky… - Blood, The Journal …, 2002 - ashpublications.org
Treatment of chronic granulomatous disease (CGD) with myeloablative bone marrow
transplantation is considered risky. This study investigated complications and survival …
transplantation is considered risky. This study investigated complications and survival …
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
Results of unrelated cord blood transplantation (UCBT) in childhood acute myeloid leukemia
(AML) have not been previously reported. We analyzed 95 children receiving UCB …
(AML) have not been previously reported. We analyzed 95 children receiving UCB …
Clinical spectrum of X-linked hyper-IgM syndrome
J Levy, T Espanol-Boren, C Thomas, A Fischer… - The Journal of …, 1997 - Elsevier
We report the clinical and immunologic features and outcome in 56 patients with X-linked
hyper-IgM syndrome, a disorder caused by mutations in the CD40 ligand gene. Upper and …
hyper-IgM syndrome, a disorder caused by mutations in the CD40 ligand gene. Upper and …
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
F Bernaudin, G Socie, M Kuentz… - Blood, The Journal …, 2007 - ashpublications.org
Allogeneic hematopoietic stem-cell transplantation (HSCT) is the only curative treatment for
sickle cell disease (SCD); nevertheless, its use has been limited by the risk of …
sickle cell disease (SCD); nevertheless, its use has been limited by the risk of …
Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the …
J Kanold, E Merlin, P Halle, C Paillard… - …, 2007 - Wiley Online Library
BACKGROUND: Extracorporeal photochemotherapy (ECP) gives positive results in the
management of graft‐versus‐host disease (GVHD), but in children, specific difficulties can …
management of graft‐versus‐host disease (GVHD), but in children, specific difficulties can …
Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation
P Bordigoni, AS Carret, V Venard, F Witz… - Clinical Infectious …, 2001 - academic.oup.com
Retrospective analysis of 303 patients who underwent allogeneic hematopoietic stem cell
transplantation identified 35 (11.5%) with adenovirus infection. Among them, 22 received …
transplantation identified 35 (11.5%) with adenovirus infection. Among them, 22 received …
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a …
Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
JP Schmid, D Canioni, D Moshous… - Blood, The Journal …, 2011 - ashpublications.org
X-linked lymphoproliferative syndromes (XLP) are primary immunodeficiencies
characterized by a particular vulnerability toward Epstein-Barr virus infection, frequently …
characterized by a particular vulnerability toward Epstein-Barr virus infection, frequently …
[HTML][HTML] Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice
OBJECTIVE: Optimizing cord blood donor selection based mainly on cell dose and human
leukocyte antigen (HLA) disparities may further improve results of unrelated cord blood …
leukocyte antigen (HLA) disparities may further improve results of unrelated cord blood …
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe …
D Blaise, M Kuentz, C Fortanier, JH Bourhis… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To compare hematologic recovery in patients receiving allogeneic blood cell
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT) …
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT) …